Cardiovascular Disease Risk Factor Intervention in Low-Income Women: The North Carolina WISEWOMAN Project

Objectives. The North Carolina WISEWOMAN project was initiated to evaluate the feasibility of expanding an existing cancer screening program to include a cardiovascular disease (CVD) screening and intervention program among low-income women. Methods. Seventeen North Carolina county health department...

Full description

Saved in:
Bibliographic Details
Published in:Preventive medicine 2000-10, Vol.31 (4), p.370-379
Main Authors: Rosamond, Wayne D., Ammerman, Alice S., Holliday, Joseph L., Tawney, Kathy W., Hunt, Kelly J., Keyserling, Thomas C., Will, Julie C., Mokdad, Ali H.
Format: Article
Language:English
Subjects:
Blood Pressure
cardiovascular disease
Cardiovascular Diseases - economics
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - etiology
Cardiovascular Diseases - prevention & control
Cholesterol - blood
Counseling
dietary factors
Feasibility Studies
Female
Humans
Hypercholesterolemia - blood
Hypercholesterolemia - complications
Hypercholesterolemia - epidemiology
intervention
Mass Screening - methods
Middle Aged
North Carolina - epidemiology
Obesity - complications
Obesity - epidemiology
Poverty
Prevalence
Risk Factors
Women's Health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives. The North Carolina WISEWOMAN project was initiated to evaluate the feasibility of expanding an existing cancer screening program to include a cardiovascular disease (CVD) screening and intervention program among low-income women. Methods. Seventeen North Carolina county health departments were designated as minimum intervention (MI), and 14 as enhanced intervention (EI). The EI included three specially constructed counseling sessions spanning 6 months using a structured assessment and intervention program tailored to lower income women. Results. Of the 2,148 women screened, 40% had elevated total cholesterol (≥240 mg/dL), 39% had low high-density lipoprotein cholesterol (HDL-C) levels (
ISSN:0091-7435
1096-0260
DOI:10.1006/pmed.2000.0726